Biologics Safety Testing Market to Worth $ 6.2 Billion by 2026 | Industry to Rise at CAGR 12.4%

Global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments.

Browse in-depth TOC on "Biologics Safety Testing Market"

142 – Tables

42 – Figures

185 – Pages

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

Key Market Players

Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg).

Growth Strategies Adopted:

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global biologics safety testing market. The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand their presence in the market.

CHARLES RIVER LABRATORIES (US)

Charles River is one of the key players in the biologics safety testing market, it is a service and early-stage contract research organization (CRO). The company develops a diverse portfolio of discovery and safety assessment services and provides a suite of products and services to support its clients’ manufacturing activities.

LONZA (SWITZERLAND)

Lonza is a key player in the biologics safety testing market. The company has a large number of manufacturing and R&D facilities across the globe. With its wide geographic presence and high production capacity, the company delivers quality products across the globe.

THERMO FISCHER SCIENTIFIC (US)

Thermo Fisher Scientific offers analytical instruments, equipment, reagents, and consumables for research, discovery, analysis, diagnostics, and manufacturing. The company operates through four principal product segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Request Sample Pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

By application, the monoclonal antibodies manufacturing segment accounted for the largest market share the Biologics safety testing market

Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. the monoclonal antibodies manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the rising prevalence of diseases and increasing government initiatives for the development of monoclonal antibody drugs.

North America accounted for the largest share of the Biologics safety testing market

North America accounted for the largest share of the biologics safety testing market . Rapid growth in the biopharmaceutical industry is the major factor driving the growth of the North American biologics safety testing market.

Speak to Analyst @  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=34624144

Article source: https://article-realm.com/article/Health-Fitness/Exercise/38943-Biologics-Safety-Testing-Market-to-Worth-6-2-Billion-by-2026-Industry-to-Rise-at-CAGR-12-4.html